ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.732,05
0,01%
S&P 500
6.040,53
-0,50%
Dow Jones
44.544,66
-0,75%
Euro vs US Dollar
1,03615
0,00%
Bitcoin
100.754,47
-1,61%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NYSE

  6. Eli Lilly and Co (LLY) Börsenkurse

Eli Lilly and Co

Eli Lilly and Co (LLY)

Eli Lilly and Company
Lilly Eli and Co
811,08
-12,15
(-1,48%)
Geschlossen 01 Februar 10:00PM
Verzögert um 15 Minuten
810,50
-0,58
(-0,07%)
Nach Börsenschluss: 1:55AM
Verzögert um 15 Minuten

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
810,50
Gebot
-
Fragen
-
Volumen
2.511.272
811,03 Tagesbereich 827,35
637,00 52-Wochen-Bereich 972,53
Marktkapitalisierung
769,42B
Handelsende
823,23
Handelsbeginn
822,00
Letzte Trade
2
@
810.49
Letzter Handelszeitpunkt
Finanzvolumen
US$ 2.061.799.892
VWAP
821,0182
Durchschnittliches Volumen (3 Mio.)
3.878.542
Ausgegebene Aktien
949.315.694
Dividendenrendite
0.74%
Kurs-Gewinn-Verhältnis
146,93
Gewinn pro Aktie (EPS)
5,52
Erlöse
34,12B
Nettogewinn
5,24B

Über Eli Lilly and Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology. Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.lilly.com
Hauptsitz
Indianapolis, Indiana, USA
Gegründet
-
Eli Lilly and Co is listed in the Pharmaceutical Preparations sector of the New York Börse with ticker LLY. The last closing price for Eli Lilly was US$823,23. Over the last year, Eli Lilly shares have traded in a share price range of US$ 637,00 to US$ 972,53.

Eli Lilly currently has 949.315.694 shares in issue. The market capitalisation of Eli Lilly is US$781,51 billion. Eli Lilly has a price to earnings ratio (PE ratio) of 146.93.

Option-Flow Eli Lilly (LLY)

Vollständigen Option-Flow anzeigen

Gesamtfluss

Bullisch

Nettoprämie

25M

Calls / Puts

322,48%

Käuf. / Verkä.

101,15%

OTM / ITM

59,82%

Sweeps

0,18%

LLY Neueste Nachrichten

Weitere Nachrichten

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

27 Januar 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

23 Januar 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

23 Januar 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

23 Januar 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

23 Januar 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

23 Januar 2025
Edgar (US Regulatory)

Lilly confirms date and conference call for fourth-quarter 2024 financial results and 2025 financial guidance announcement

Lilly confirms date and conference call for fourth-quarter 2024 financial results and 2025 financial guidance announcement PR Newswire INDIANAPOLIS, Jan. 23, 2025 INDIANAPOLIS, Jan. 23, 2025...

23 Januar 2025
PR Newswire (US)

FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease

FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease PR Newswire INDIANAPOLIS, Jan. 15, 2025 In the pivotal...

15 Januar 2025
PR Newswire (US)

Form 8-K - Current report

14 Januar 2025
Edgar (US Regulatory)

Lilly provides update on 2024 revenue guidance, announces 2025 revenue guidance

Lilly provides update on 2024 revenue guidance, announces 2025 revenue guidance PR Newswire INDIANAPOLIS, Jan. 14, 2025 2024 revenue is expected to be approximately $45.0 billion for the full...

14 Januar 2025
PR Newswire (US)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
152.56.92612137203758824.627583049804803.48790005CS
4324.11046885035778.5824.62725.014051154768.94638173CS
127.50.93399750934803847.27711.40013878542776.32035945CS
2610.111.26313422207800.39972.53711.40013523622831.18846762CS
52160.1224.6194532427650.38972.536373252233814.60237763CS
156567.23233.168906976243.27972.53231.873063944547.73115899CS
260667.69467.537287305142.81972.53116.553285306386.58488398CS

LLY - Frequently Asked Questions (FAQ)

What is the current Eli Lilly share price?
The current share price of Eli Lilly is US$ 810,50
How many Eli Lilly shares are in issue?
Eli Lilly has 949.315.694 shares in issue
What is the market cap of Eli Lilly?
The market capitalisation of Eli Lilly is USD 781,51B
What is the 1 year trading range for Eli Lilly share price?
Eli Lilly has traded in the range of US$ 637,00 to US$ 972,53 during the past year
What is the PE ratio of Eli Lilly?
The price to earnings ratio of Eli Lilly is 146,93
What is the cash to sales ratio of Eli Lilly?
The cash to sales ratio of Eli Lilly is 22,56
What is the reporting currency for Eli Lilly?
Eli Lilly reports financial results in USD
What is the latest annual turnover for Eli Lilly?
The latest annual turnover of Eli Lilly is USD 34,12B
What is the latest annual profit for Eli Lilly?
The latest annual profit of Eli Lilly is USD 5,24B
What is the registered address of Eli Lilly?
The registered address for Eli Lilly is 334 NORTH SENATE AVENUE, INDIANAPOLIS, INDIANA, 46204
What is the Eli Lilly website address?
The website address for Eli Lilly is www.lilly.com
Which industry sector does Eli Lilly operate in?
Eli Lilly operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
MBIMBIA Inc
US$ 7,11
(15,42%)
2,37M
ALURAllurion Technologies Inc
US$ 6,07
(13,46%)
571,74k
SESSES AI Corporation
US$ 1,19
(13,33%)
24,78M
ENFYEnlightify Inc
US$ 1,36
(12,40%)
95,69k
LITBLightInTheBox Holding Co Ltd
US$ 1,155
(12,14%)
17,51k
DECKDeckers Outdoor
US$ 177,46
(-20,46%)
15,04M
BZHBeazer Homes USA Inc New
US$ 22,18
(-19,93%)
2,11M
VSTSVestis Corporation
US$ 14,00
(-11,62%)
6,16M
KOREKORE Group Holdings Inc
US$ 2,29
(-9,13%)
36,39k
NOVASunnova Energy International Inc
US$ 2,565
(-9,04%)
14,63M
FFord Motor Company
US$ 10,08
(-0,79%)
103,99M
QBTSD Wave Quantum Inc
US$ 5,94
(5,32%)
75,07M
BBDBanco Bradesco SA
US$ 2,12
(0,47%)
55,89M
NUNu Holdings Ltd
US$ 13,25
(-1,41%)
48,21M
VZVerizon Communications Inc
US$ 39,39
(-0,20%)
45,19M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NYSE
LLY
Eli Lilly
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten